Mangoceuticals, Inc. is primarily focused on developing, marketing, and selling a variety of men’s health and wellness products and services via a secure telemedicine platform. The Company has developed and is commercially marketing a new brand of erectile dysfunction (ED) products under the brand name Mango and a brand of hair loss products under the brand name Grow. These products are produced at a compounding pharmacy using a proprietary combination of United States Food and Drug Administration (FDA) approved ingredients and are available to patients on the determination of a prescribing physician that the compounded drug is necessary for the individual patient. It is marketing and selling these branded ED and hair loss products exclusively online via its Website at www.MangoRx.com. Its customer platform connects consumers to licensed healthcare professionals through its Website for the provision of care via telehealth. It also owns a global patent portfolio of oral solution.
企業コードMGRX
会社名Mangoceuticals Inc
上場日Mar 21, 2023
最高経営責任者「CEO」Mr. Jacob D. Cohen
従業員数- -
証券種類Ordinary Share
決算期末Mar 21
本社所在地15110 Dallas Pkwy, Suite 600
都市DALLAS
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号75248
電話番号18336264679
ウェブサイトhttps://www.mangorx.com/
企業コードMGRX
上場日Mar 21, 2023
最高経営責任者「CEO」Mr. Jacob D. Cohen
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし